Should the French breast cancer screening programme be extended to women aged 40-49? Update
L'Agence Nationale d'Accreditation d'Evaluation en Sante (ANAES)
Record Status
This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database.
Citation
L'Agence Nationale d'Accreditation d'Evaluation en Sante (ANAES). Should the French breast cancer screening programme be extended to women aged 40-49? Update. Paris: L'Agence Nationale d'Accreditation d'Evaluation en Sante (ANAES) 2004: 96
Authors' objectives
This study aimed to assess whether the French breast cancer screening programme should be extended to women aged 40-49 with no history of breast cancer or hereditary risk, using WHO criteria. This is an update of the ANAES 1999 guidelines.
Authors' conclusions
No extension of the French breast cancer screening programme to women aged 40-49 should be envisaged until efficacy and cost-effectiveness in older women (50-74 years) have been proven.